]> Subscribe to the latest newsworthy research about Myasthenia Gravis as soon as it is published in <em>Neurology</em>^&reg;, the medical journal of the American Academy of Neurology. <em>Neurology</em> is the world's most widely read and highly cited peer-reviewed neurology journal. http://www.aan.com/rss/?event=feed&channel=10 en ababb@aan.com kwiersma@aan.com Thu, 13 Nov 2008 16:29:35 GMT Sat, 21 Nov 2009 07:19:07 GMT AXON RSS Extension http://blogs.law.harvard.edu/tech/rss ababb@aan.com Channel Feedback http://www.aan.com/rss/?event=feed&channel=10 http://www.aan.com/rss/images/channels/channel_10_s.jpg 144 144 Subscribe to the latest newsworthy research about Myasthenia Gravis as soon as it is published in <em>Neurology</em>^&reg;, the medical journal of the American Academy of Neurology. <em>Neurology</em> is the world's most widely read and highly cited peer-reviewed neurology journal. false 1 http://www.aan.com/rss/index.cfm/getfile/AAN_94.pdf Media Contacts: Angela Babb, ababb@aan.com, (651) 695-2789 Rachel Seroka, rseroka@aan.com, (651) 695-2738 AAN Launches New Book Series to Help Patients and Caregivers ST. PAUL, Minn. - Following up on the success of Neurology Now&reg;, the free and award-winning patient and caregiver magazine of the American Academy of Neurology, the Academy has announced plans to launch a new series of books for neurology patients and caregivers in 2009 to be called Neurology Now Books&trade;. The Academy has expanded its publishing division, AAN Press, to publish this new book series. Titles planned to publish in the Neurology Now Books&trade; series include coping with multiple sclerosis, brain tumors, and taste and smell disorders in the first year. A fourth publication is also planned for late next year. "With one in six people now affected by a neurologic disorder, there's tremendous demand for the latest information on how to best meet the needs of this fast-growing population of patients and caregivers. Neurology Now Books&trade; will fulfill this growing demand," said Lisa M. Shulman, MD, Editor of Neurology Now Books&trade;, and a neurologist with the University of Maryland School of Medicine and Fellow of the American Academy of Neurology. "With the experience the Academy has had in publishing Neurology Now&reg; magazine, it's sought to advance patient care and has developed an appreciation for the needs and concerns of neurology patients and caregivers. Neurology Now Books&trade; will continue to further our mission of improving patient care and public understanding of disorders of the brain and nervous system," said Shulman. Each issue of Neurology Now&reg; magazine reaches nearly one million readers. It is the only consumer magazine in the country devoted to the management of the range of neurologic disorders. The magazine offers information on treatment and cutting-edge research for such neurologic disorders as Alzheimer's disease, epilepsy, migraine, Parkinson's disease and more. For information on receiving a free subscription to Neurology Now&reg; magazine, visit www.neurologynow.com. AAN Press through Demos Medical Publishing published an earlier series of books for neurology patients and caregivers that will continue to be available for purchase via the AAN Store&trade;. Other AAN Press publications are Neurology&reg;, the most widely read and highly cited peer-reviewed neurology journal, Neurology Now&reg; magazine, and Neurology Today&reg;. The American Academy of Neurology, an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as stroke, Alzheimer's disease, epilepsy, Parkinson's disease, and multiple sclerosis. For more information about the American Academy of Neurology, visit www.aan.com. http://www.aan.com/rss/index.cfm/getfile/AAN_94.pdf ababb@aan.com Tue, 23 Sep 2008 15:04:51 GMT 1 http://www.aan.com/rss/index.cfm/getfile/AAN_1895.pdf The American Academy of Neurology (AAN) Foundation and the Myasthenia Gravis Foundation of America (MGFA) are pleased to announce the creation of a three-year Clinician Scientist Development Fellowship Award to support research related to myasthenia gravis. The deadline for applying is October 1, 2009. The $240,000 fellowship will be awarded to the recipient over a three-year period. The AAN Foundation/MGFA Clinician Scientist Development Fellowship is designed to recognize the importance of excellent clinical research and encourage young investigators in clinical studies with the goal of providing better treatment, prevention or cure for the disorder. "This substantial award will allow for the necessary support for new discoveries by a remarkable young clinician scientist," said Foundation Chair Austin J. Sumner, MD, FAAN. "The AAN Foundation is committed to escalating the role of neurological research by contributing to innovative study designs." "The partnership represents an exciting opportunity for MGFA to leverage our resources as we look for ways to improve the daily lives of individuals with myasthenia gravis and develop the next generation of researchers and clinicians," said Tor Holtan, MGFA Chief Executive. The fellowship includes tuition reimbursement for education in clinical research methodology. The award will be formally presented at the 62nd AAN Annual Meeting in Toronto in April 2010. Myasthenia gravis (MG) is an autoimmune neuromuscular disorder that affects voluntary muscles. Common symptoms can include a drooping eyelid, blurred or double vision, slurred speech, difficulty chewing and swallowing, weakness in the arms and legs, chronic muscle fatigue and difficulty breathing. In the United States, roughly 20 of every 100,000 people are diagnosed with MG, and there is currently no known cure for the disorder. Myasthenia gravis occurs in all races, both genders, and at any age, and is not thought to be directly inherited. The American Academy of Neurology, an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as epilepsy, dystonia, migraine, Huntington's disease, and dementia. For more information about the American Academy of Neurology Foundation, visit www.aan.com/foundation. http://www.aan.com/rss/index.cfm/getfile/AAN_1895.pdf ababb@aan.com Tue, 14 Apr 2009 16:46:13 GMT